Growth Metrics

Nexalin Technology (NXL) Other Gross PP&E Adjustments (2022 - 2023)

Nexalin Technology's quarterly Other Gross PP&E Adjustments came in at -$496.0 in Q4 2023, up 91.96% year-on-year from -$258.38 in Q4 2022, and up 74.73% quarter-over-quarter from -$1963.0 in Q3 2023.

Nexalin Technology has reported Other Gross PP&E Adjustments for 2 years, with the latest figure at -$496.0 in Q4 2023.

  • For the quarter ending Q4 2023, Other Gross PP&E Adjustments rose 91.96% year-over-year to -$496.0; the trailing twelve-month figure through Dec 2023 stood at -$496.0 (up 91.96% YoY), and the FY2023 full-year result was -$496.0, up 91.96% from the prior year.
  • Other Gross PP&E Adjustments for Q4 2023 stood at -$496.0, up from -$1963.0 in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was -$496.0 in Q4 2023, with the low at -$7512.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 23.14 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -405.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -547.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -99.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.55 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.39 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 991.00 Mn
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 -496.00
Dec 31, 2023 -496.00
Sep 30, 2023 -1,963.00
Sep 30, 2023 -1,963.00
Jun 30, 2023 -3,397.00
Jun 30, 2023 -3,397.00
Mar 31, 2023 -4,800.00
Mar 31, 2023 -4,800.00
Dec 31, 2022 -6,171.00
Dec 31, 2022 -6,171.00
Sep 30, 2022 -7,512.00
Sep 30, 2022 -7,512.00